US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.580
- -0.051-8.14%
Close Dec 13 16:00 ET
- 0.586
- +0.006+1.00%
Post 19:07 ET
148.44MMarket Cap-3.47P/E (TTM)
0.615High0.551Low3.03MVolume0.601Open0.632Pre Close1.75MTurnover1.75%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High1.85P/B100.86MFloat Cap0.43052wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM10.18%Amplitude0.420Historical Low0.578Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2014
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- William C. Bertrand, Jr
- Chief Operating Officer
- 1.22M
- John Lunger
- Chief Patient Supply Officer
- --
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- Cintia Piccina
- Chief Commercial Officer
- --
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- David M. Mott
- Chairman of the Board
- 174.83K
- Lawrence M. Alleva
- Independent Director
- 128.80K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
- John P. Furey
- Independent Director
- 117.25K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
